OrbiMed Israel BioFund GP Limited Partnership 13D and 13G filings for NOVUS THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-18 4:35 pm Unchanged |
2020-08-14 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 16.400% |
0 (Unchanged) |
Filing |